Using Discrete Choice Experiment to elicit patient preferences for osteoporosis drug treatments: Where to from here?

Laba, TL

Using Discrete Choice Experiment to elicit patient preferences for osteoporosis drug treatments: Where to from here?

Laba, TL

Permalink

Publication Type:: Journal Article
Citation:: Arthritis Research and Therapy, 2014, 16 (2)
Issue Date:: 2014-03-10

Open Access

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is open access.

Adobe PDF

Download Published VersionAdobe PDF (216.57 kB)

View on publisher's site

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Laba, TL https://orcid.org/0000-0002-5182-9092	en_US
dc.date.issued	2014-03-10	en_US
dc.identifier.citation	Arthritis Research and Therapy, 2014, 16 (2)	en_US
dc.identifier.issn	1478-6354	en_US
dc.identifier.uri	http://hdl.handle.net/10453/135168
dc.description.abstract	Osteoporosis is a disease that increases skeletal fracture risk and places a significant health and economic burden on patients, families, and health systems. Many treatment options exist, but patient use is suboptimal, thus undermining the potential cost-effectiveness of treatments. In the previous issue of Arthritis Research & Therapy, Hiligsmann and colleagues expanded the findings of previous studies to report, from a sample of 257 patients with osteoporosis, the preference to trade off clinical outcomes for the amenity provided by convenient dosing regimens. This editorial critiques the strengths and limitations of the methods, discusses the potential utility of patient treatment preferences, and suggests avenues for further research. © 2014 BioMed Central Ltd.	en_US
dc.relation.ispartof	Arthritis Research and Therapy	en_US
dc.relation.isbasedon	10.1186/ar4501	en_US
dc.subject.classification	Arthritis & Rheumatology	en_US
dc.subject.mesh	Humans	en_US
dc.subject.mesh	Osteoporosis	en_US
dc.subject.mesh	Choice Behavior	en_US
dc.subject.mesh	Female	en_US
dc.subject.mesh	Male	en_US
dc.subject.mesh	Bone Density Conservation Agents	en_US
dc.subject.mesh	Patient Preference	en_US
dc.title	Using Discrete Choice Experiment to elicit patient preferences for osteoporosis drug treatments: Where to from here?	en_US
dc.type	Journal Article
utslib.citation.volume	2	en_US
utslib.citation.volume	16	en_US
utslib.for	1103 Clinical Sciences	en_US
utslib.for	1107 Immunology	en_US
utslib.for	1117 Public Health and Health Services	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Business
pubs.organisational-group	/University of Technology Sydney/Strength - CHERE - Centre for Health Economics Research and Evaluation
utslib.copyright.status	open_access
pubs.issue	2	en_US
pubs.publication-status	Published	en_US
pubs.volume	16	en_US

Abstract:

Osteoporosis is a disease that increases skeletal fracture risk and places a significant health and economic burden on patients, families, and health systems. Many treatment options exist, but patient use is suboptimal, thus undermining the potential cost-effectiveness of treatments. In the previous issue of Arthritis Research & Therapy, Hiligsmann and colleagues expanded the findings of previous studies to report, from a sample of 257 patients with osteoporosis, the preference to trade off clinical outcomes for the amenity provided by convenient dosing regimens. This editorial critiques the strengths and limitations of the methods, discusses the potential utility of patient treatment preferences, and suggests avenues for further research. © 2014 BioMed Central Ltd.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/135168